Show simple item record

dc.contributor.authorDobšíček Trefná, H.en_US
dc.contributor.authorSchmidt, M.en_US
dc.contributor.authorvan Rhoon, G.C.en_US
dc.date.accessioned2019-09-13T16:42:02Z
dc.date.available2019-09-13T16:42:02Z
dc.date.issued2019
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85060648017&doi=10.1080%2f02656736.2018.1564155&partnerID=40&md5=d39bf82ceea274f3ad7f344977996f0c
dc.identifier.urihttp://hdl.handle.net/10713/10734
dc.description.abstractQuality assurance (QA) guidelines are essential to provide uniform execution of clinical hyperthermia treatments and trials. This document outlines the clinical and technical consequences of the specific properties of interstitial heat delivery and specifies recommendations for hyperthermia administration with interstitial techniques. Interstitial hyperthermia aims at tumor temperatures in the 40–44 °C range as an adjunct to radiation or chemotherapy. The clinical part of this document imparts specific clinical experience of interstitial heat delivery to various tumor sites as well as recommended interstitial hyperthermia workflow and procedures. The second part describes technical requirements for quality assurance of current interstitial heating equipment including electromagnetic (radiative and capacitive) and ultrasound heating techniques. Detailed instructions are provided on characterization and documentation of the performance of interstitial hyperthermia applicators to achieve reproducible hyperthermia treatments of uniform high quality. Output power and consequent temperature rise are the key parameters for characterization of applicator performance in these QA guidelines. These characteristics determine the specific maximum tumor size and depth that can be heated adequately. The guidelines were developed by the ESHO Technical Committee with participation of senior STM members and members of the Atzelsberg Circle. Copyright 2019 The Author(s). Published with license by Taylor & Francis Group, LLC.en_US
dc.description.urihttps://doi.org/10.1080/02656736.2018.1564155en_US
dc.language.isoen-USen_US
dc.publisherTaylor and Francis Ltden_US
dc.relation.ispartofInternational Journal of Hyperthermia
dc.subjectClinicalen_US
dc.subjecthyperthermiaen_US
dc.subjectinterstitialen_US
dc.subjectquality assuranceen_US
dc.titleQuality assurance guidelines for interstitial hyperthermiaen_US
dc.typeArticleen_US
dc.identifier.doi10.1080/02656736.2018.1564155
dc.identifier.pmid30676101


This item appears in the following Collection(s)

Show simple item record